急性白血病初始诊断检查:ASCO临床实践指南对美国病理学家学会与美国血液学会指南的背书
美国病理学家学会(CAP)与美国血液学会(ASH)制定了急性白血病(AL)初始诊断检查的循证指南。ASCO方法学家审查其制定严谨性,ASCO背书专家小组更新文献检索并审核内容与推荐,认定该2016年发布的指南推荐清晰、全面且基于最相关科学证据,ASCO完全背书该CAP-ASH指南,并按临床实践与更新文献补充若干讨论要点。
要点
- ASCO完全背书CAP-ASH急性白血病初始诊断检查指南。
- 共审核27条指南声明,并补充讨论要点。
- 讨论要点涵盖中枢神经系统受累评估、分子诊断与风险分层及靶向治疗潜在标志物。
核心结论
- ASCO专家小组认定2016年发布的CAP-ASH急性白血病初始诊断检查指南推荐清晰、全面且基于最相关科学证据,ASCO完全背书该指南。
研究设计与样本
- CAP与ASH制定急性白血病初始诊断检查的循证指南,ASCO方法学家审查其制定严谨性,ASCO背书专家小组更新文献检索并审核内容与推荐。
主要发现
- 共审核27条指南声明,ASCO完全背书CAP-ASH指南。
- 补充讨论要点以更好评估白血病中枢神经系统受累,并为分子诊断及风险分层与靶向治疗的潜在标志物提供新见解。
关键数值与推荐
- 讨论要点分为四部分:初始诊断侧重基础诊断与风险参数确定;分子标志物与微小残留病检测;转诊至具有急性白血病管理专长的另一机构的情景;报告与记录保存以更好概述和随访讨论。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The College of American Pathologists (CAP) and the American Society of Hematology (ASH) developed an evidence-based guideline on the initial diagnostic work-up of acute leukemia (AL). Because of the relevance of this topic to the ASCO membership, ASCO reviewed the guideline and applied a set of procedures and policies for endorsing clinical practice guidelines that have been developed by other professional organizations. METHODS: The CAP-ASH guideline on initial diagnostic work-up of AL was reviewed for developmental rigor by methodologists. Then, an ASCO Endorsement Expert Panel updated the literature search and reviewed the content and recommendations. RESULTS: The ASCO Expert Panel determined that the recommendations from the guideline, published in 2016, are clear, thorough, and based on the most relevant scientific evidence. ASCO fully endorsed the CAP-ASH guideline on initial diagnostic work-up of AL and included some discussion points according to clinical practice and updated literature. CONCLUSION: Twenty-seven guideline statements were reviewed. Some discussion points were included to better assess CNS involvement in leukemia and to provide novel insights into molecular diagnosis and potential markers for risk stratification and target therapy. These discussions are categorized into four sections: (1) initial diagnosis focusing on basic diagnostics and determination of risk parameters, (2) molecular markers and minimal residual disease detection, (3) context of referral to another institution with expertise in the management of AL, and (4) reporting and record keeping for better outlining and follow-up discussion. Additional information is available at: www.asco.org/hematologic-malignancies-guidelines .
引用
- de Haas V, Ismaila N, Advani A, et al. Initial Diagnostic Work-Up of Acute Leukemia: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists and American Society of Hematology Guideline. J Clin Oncol. 2018. PMID: 30523709. doi:10.1200/JCO.18.01468
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。